New Delhi, Apr 24: Two Chinese companies that are manufacturing the Covid-19 rapid antibody test kits have expressed shock and surprise after the Indian Council for Medical Research (ICMR) halted surveillance testing for two days.
They said that the products had been approved by the Indian Council of Medical Research (ICMR) and the National Institute of Virology. ''Wondfo received import license from India for Wondfo SARS-CoV-2 Antibody Test [Lateral Flow Method] on March 20, 2020. And the product was validated and approved by the ICMR through National Institute of Virology [NIV], Pune,'' said a statement from Wondfo, one of the major global suppliers of rapid testing kits for COVID-19 viral infection.
Another Chinese firm Livzon Diagnostics Inc also issued a statement on the same lines. The explanations from both the companies clarified that the tests had to be conducted within laid down procedures and violation of the laid down procedures could disturb the test results.
They promised to cooperate with Indian authorities to investigate the reported malfunctioning and said the products met the ISO 9001 standard. The companies said they are among the most reputed global suppliers of rapid testing kits for COVID-19 and have supplied the same to 70 countries and regions, including the United States and many other European and Latin American countries. MORE (UNI)